Three Cases Of Pulmonary Adenocarcinoma In Which Epidermal Growth Factor Receptor (EGFR) Exon 20 T790m Resistance Mutations In Pleural Fluids Disappeared

被引：0
|
作者：
Kodama, T. [1 ]
Watanabe, K. [1 ]
Nagai, K. [2 ]
Shinoda, M. [1 ]
Shinkai, M. [1 ]
Kaneko, T. [2 ]
机构：
[1] Resp Dis Ctr, Dept Internal Med, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparing outcomes of patients with epidermal growth factor receptor (EGFR) therapy resistant mutations (EXON 20 and T790M)
    Enver, M.
    Khalid, F.
    Khan, S.
    Ahmed, S.
    [J]. LUNG CANCER, 2019, 127 : S39 - S39
  • [2] Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations.
    Riely, Gregory J.
    Yu, Helena Alexandra
    Arcila, Maria E.
    Hellmann, Matthew David
    Ladanyi, Marc
    Kris, Mark G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials
    O'Kane, G. M.
    Barnes, T. A.
    Leighl, N. B.
    [J]. CURRENT ONCOLOGY, 2018, 25 : S28 - S37
  • [4] Concurrent Molecular Alterations in Tumors With Germ Line Epidermal Growth Factor Receptor T790M Mutations
    Thomas, Anish
    Xi, Liqiang
    Carter, Corey A.
    Rajan, Arun
    Khozin, Sean
    Szabo, Eva
    Dennis, Phillip A.
    Giaccone, Giuseppe
    Raffeld, Mark
    [J]. CLINICAL LUNG CANCER, 2013, 14 (04) : 452 - 456
  • [5] Characterization of the Epidermal Growth Factor Receptor T790M Mutation in Colorectal Cancer
    Altunel, Erdem
    Aljamal, Abed Alhalim
    Mantyh, John
    Deak, Kristen
    Glover, Wayne
    Mccall, Shannon J.
    Datto, Michael
    Strickler, John
    Hsu, David S.
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 7
  • [6] Case report of three EGFR TKI naive lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology
    Sakashita, Shingo
    Shiba-Ishii, Aya
    Murata, Yoshihiko
    Sekimoto, Ryutaro
    Minami, Yuko
    Sato, Yukio
    Noguchi, Masayuki
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (08) : 1224 - 1230
  • [7] Effects of Vandetanib on Lung Adenocarcinoma Cells Harboring Epidermal Growth Factor Receptor T790M Mutation In vivo
    Ichihara, Eiki
    Ohashi, Kadoaki
    Takigawa, Nagio
    Osawa, Masahiro
    Ogino, Atsuko
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. CANCER RESEARCH, 2009, 69 (12) : 5091 - 5098
  • [8] A Long-Survival Patient with Advanced Lung Adenocarcinoma with the Epidermal Growth Factor Receptor T790M Mutation
    Cabrita, B.
    Cipriano, E.
    Amaro, T.
    Cirnes, L.
    Magalhaes, H.
    Estevinho, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance
    Xu, Song
    Liu, Xia
    Liu, Renwang
    Shi, Tao
    Li, Xiongfei
    Zhong, Diansheng
    Wang, Yan
    Chen, Gang
    Chen, Jun
    [J]. THORACIC CANCER, 2017, 8 (06) : 693 - 697
  • [10] Osimertinib Did Not Respond to a Pulmonary Adenocarcinoma with Triple Mutations of Epidermal Growth Factor Receptor, G719S, T790M and S768I
    Minami, Seigo
    Ihara, Shouichi
    Tanaka, Tsunehiro
    Okada, Hideyasu
    Hashimoto, Kazuki
    Komuta, Kiyoshi
    [J]. CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 178 - 182
12345